{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:53:11Z","timestamp":1791575591077,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82260169"],"award-info":[{"award-number":["No. 82260169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science & Technology Department of Jiangxi Province","award":["No. 20224ACB216003"],"award-info":[{"award-number":["No. 20224ACB216003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04082-1","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:53:17Z","timestamp":1773489197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selenium-loaded sustained-release schizophyllan alleviates pancreatic and pulmonary inflammatory damage in type 1 diabetes mellitus by modulating gut microbiota and T cell balance"],"prefix":"10.1186","volume":"24","author":[{"given":"Junming","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqing","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"3","key":"4082_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.6065\/apem.2019.24.3.143","volume":"24","author":"HS Lee","year":"2019","unstructured":"Lee HS, Hwang JS. Genetic aspects of type 1 diabetes. Ann Pediatr Endocrinol Metab. 2019;24(3):143\u20138. https:\/\/doi.org\/10.6065\/apem.2019.24.3.143.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"10","key":"4082_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101736","volume":"13","author":"K Siddiqui","year":"2023","unstructured":"Siddiqui K, Nawaz SS, Alfadda AA, Mujammami M. Islet autoantibodies to pancreatic insulin-producing beta cells in adolescent and adults with type 1 diabetes mellitus: a cross-sectional study. Diagnostics. 2023;13(10):1736. https:\/\/doi.org\/10.3390\/diagnostics13101736.","journal-title":"Diagnostics"},{"issue":"4","key":"4082_CR3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00125-024-06356-5","volume":"68","author":"J Collins","year":"2025","unstructured":"Collins J, Farnsworth NL. Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Diabetologia. 2025;68(4):692\u2013703. https:\/\/doi.org\/10.1007\/s00125-024-06356-5.","journal-title":"Diabetologia"},{"key":"4082_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756548","author":"E Toren","year":"2021","unstructured":"Toren E, Burnette KS, Banerjee RR, Hunter CS, Tse HM. Partners in crime: Beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.756548.","journal-title":"Front Immunol"},{"issue":"4","key":"4082_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.stem.2020.09.008","volume":"27","author":"JA Bluestone","year":"2020","unstructured":"Bluestone JA, Tang Q. Solving the puzzle of immune tolerance for \u03b2-Cell replacement therapy for type 1 diabetes. Cell Stem Cell. 2020;27(4):505\u20137. https:\/\/doi.org\/10.1016\/j.stem.2020.09.008.","journal-title":"Cell Stem Cell"},{"key":"4082_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110085","volume":"192","author":"J Chen","year":"2022","unstructured":"Chen J, Yi Q, Wang Y, et al. Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: a systematic review and meta-analysis of cohort studies. Diabetes Res Clin Pract. 2022;192:110085. https:\/\/doi.org\/10.1016\/j.diabres.2022.110085.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"4082_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jdi.12147","volume":"5","author":"C Chang","year":"2013","unstructured":"Chang C, Chuang L. Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: is month-to\u2010moth instability a better predictor? J Diabetes Invest. 2013;5(2):149\u201352. https:\/\/doi.org\/10.1111\/jdi.12147.","journal-title":"J Diabetes Invest"},{"issue":"2","key":"4082_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98\u2013115. https:\/\/doi.org\/10.34172\/hpp.2020.18.","journal-title":"Health Promot Perspect"},{"issue":"2","key":"4082_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41390-024-03107-5","volume":"97","author":"B Gong","year":"2024","unstructured":"Gong B, Yang W, Xing Y, Lai Y, Shan Z. Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatr Res. 2024;97(2):568\u201376. https:\/\/doi.org\/10.1038\/s41390-024-03107-5.","journal-title":"Pediatr Res"},{"issue":"6","key":"4082_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/dia.2024.0498","volume":"27","author":"C Schaaf","year":"2025","unstructured":"Schaaf C, Sussel L. A cure for type 1 diabetes: are we there yet? Diabetes Technol Ther. 2025;27(6):413\u201321. https:\/\/doi.org\/10.1089\/dia.2024.0498.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"4082_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/med.0000000000000646","volume":"28","author":"N Erdem","year":"2021","unstructured":"Erdem N, Montero E, Roep BO. Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2021;28(4):397\u2013403. https:\/\/doi.org\/10.1097\/med.0000000000000646.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"4082_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012;8(3):e1002552. https:\/\/doi.org\/10.1371\/journal.pgen.1002552.","journal-title":"PLoS Genet"},{"key":"4082_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365554","author":"X Wang","year":"2024","unstructured":"Wang X, Yuan W, Yang C, et al. Emerging role of gut microbiota in autoimmune diseases. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1365554.","journal-title":"Front Immunol"},{"key":"4082_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.946248","author":"A Christovich","year":"2022","unstructured":"Christovich A, Luo XM. Gut microbiota, leaky gut, and autoimmune diseases. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.946248.","journal-title":"Front Immunol"},{"issue":"1","key":"4082_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","volume":"42","author":"T Takeuchi","year":"2024","unstructured":"Takeuchi T, Nakanishi Y, Ohno H. Microbial metabolites and gut immunology. Annu Rev Immunol. 2024;42(1):153\u201378. https:\/\/doi.org\/10.1146\/annurev-immunol-090222-102035.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"4082_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.11406\/rinketsu.62.900","volume":"62","author":"H Ohno","year":"2021","unstructured":"Ohno H. Gut microbiota, immunity, and autoimmune diseases. Rinsho Ketsueki. 2021;62(8):900\u20138. https:\/\/doi.org\/10.11406\/rinketsu.62.900.","journal-title":"Rinsho Ketsueki"},{"key":"4082_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109873","volume":"124","author":"Q Ma","year":"2020","unstructured":"Ma Q, Li Y, Wang J, et al. Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing. Biomed Pharmacother. 2020;124:109873. https:\/\/doi.org\/10.1016\/j.biopha.2020.109873.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4082_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1538\/expanim.24-0125","volume":"74","author":"X Fu","year":"2025","unstructured":"Fu X, Ren X, Zhao M, et al. Disruption of intestinal barrier and dysbiosis of gut microbiota in an experimental rhesus macaque model with 6-year diabetes mellitus. Exp Anim. 2025;74(4):384\u201398. https:\/\/doi.org\/10.1538\/expanim.24-0125.","journal-title":"Exp Anim"},{"key":"4082_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-024-03843-6","author":"C Xu","year":"2024","unstructured":"Xu C, Hao M, Zai X, et al. A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases. Arch Microbiol. 2024. https:\/\/doi.org\/10.1007\/s00203-024-03843-6.","journal-title":"Arch Microbiol"},{"issue":"11","key":"4082_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13111005","volume":"13","author":"M Druszczynska","year":"2024","unstructured":"Druszczynska M, Sadowska B, Kulesza J, G\u0105sienica-Gliwa N, Kulesza E, Fol M. The intriguing connection between the gut and lung microbiomes. Pathogens. 2024;13(11):1005. https:\/\/doi.org\/10.3390\/pathogens13111005.","journal-title":"Pathogens"},{"key":"4082_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217096","volume":"598","author":"X Li","year":"2024","unstructured":"Li X, Shang S, Wu M, Song Q, Chen D. Gut microbial metabolites in lung cancer development and immunotherapy: novel insights into gut-lung axis. Cancer Lett. 2024;598:217096. https:\/\/doi.org\/10.1016\/j.canlet.2024.217096.","journal-title":"Cancer Lett"},{"issue":"1","key":"4082_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4049\/jimmunol.2001304","volume":"207","author":"Q Pu","year":"2021","unstructured":"Pu Q, Lin P, Gao P, et al. Gut microbiota regulate gut\u2013lung axis inflammatory responses by mediating ILC2 compartmental migration. J Immunol. 2021;207(1):257\u201367. https:\/\/doi.org\/10.4049\/jimmunol.2001304.","journal-title":"J Immunol"},{"issue":"4","key":"4082_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"Dang AT, Marsland BJ. Microbes, metabolites, and the gut\u2013lung axis. Mucosal Immunol. 2019;12(4):843\u201350. https:\/\/doi.org\/10.1038\/s41385-019-0160-6.","journal-title":"Mucosal Immunol"},{"key":"4082_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107272","volume":"91","author":"J Tang","year":"2021","unstructured":"Tang J, Xu L, Zeng Y, Gong F. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4\/NF-kB signaling pathway. Int Immunopharmacol. 2021;91:107272. https:\/\/doi.org\/10.1016\/j.intimp.2020.107272.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4082_CR25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.kint.2020.04.048","volume":"98","author":"J Yang","year":"2020","unstructured":"Yang J, Kim CJ, Go YS, et al. Intestinal microbiota control acute kidney injury severity by immune modulation. Kidney Int. 2020;98(4):932\u201346. https:\/\/doi.org\/10.1016\/j.kint.2020.04.048.","journal-title":"Kidney Int"},{"key":"4082_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113570","volume":"143","author":"J Wang","year":"2024","unstructured":"Wang J, Hou Y, Mu L, Yang M, Ai X. Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17\/Treg cells. Int Immunopharmacol. 2024;143:113570. https:\/\/doi.org\/10.1016\/j.intimp.2024.113570.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4082_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121\u201341. https:\/\/doi.org\/10.1016\/j.cell.2014.03.011.","journal-title":"Cell"},{"issue":"2","key":"4082_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A Trompette","year":"2014","unstructured":"Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 2014;20(2):159\u201366. https:\/\/doi.org\/10.1038\/nm.3444.","journal-title":"Nat Med"},{"key":"4082_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105946","volume":"120","author":"J Li","year":"2025","unstructured":"Li J, Liang X, Zhao M, et al. Monocyte\/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226\u2009+\u2009B cells in type 1 diabetes. EBioMedicine. 2025;120:105946. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105946.","journal-title":"EBioMedicine"},{"issue":"4","key":"4082_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/1872210517666230803091245","volume":"18","author":"A Jain","year":"2024","unstructured":"Jain A, Dawre S. A comprehensive review on prospects of polymeric nanoparticles fortreatment of diabetes mellitus: receptors-ligands, in vitro & in vivo studies. NANOTEC. 2024;18(4):457\u201378. https:\/\/doi.org\/10.2174\/1872210517666230803091245.","journal-title":"NANOTEC"},{"issue":"39","key":"4082_CR31","doi-asserted-by":"publisher","first-page":"392001","DOI":"10.1088\/1361-6528\/ad5db5","volume":"35","author":"J Verma","year":"2024","unstructured":"Verma J, Dahiya S. Nanomaterials for diabetes: diagnosis, detection and delivery. Nanotechnology. 2024;35(39):392001. https:\/\/doi.org\/10.1088\/1361-6528\/ad5db5.","journal-title":"Nanotechnology"},{"issue":"7","key":"4082_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070945","volume":"17","author":"A Caturano","year":"2024","unstructured":"Caturano A, Nilo R, Nilo D, et al. Advances in nanomedicine for precision insulin delivery. Pharmaceuticals. 2024;17(7):945. https:\/\/doi.org\/10.3390\/ph17070945.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"4082_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/biology13040253","volume":"13","author":"DY Khalil","year":"2024","unstructured":"Khalil DY, Hussein RH, El-Kholy WM. Mesenchymal stem cell-derived exosomes loaded with selenium or nano selenium as a novel therapeutic paradigm for streptozotocin-induced type 1 diabetes in rats. Biology. 2024;13(4):253. https:\/\/doi.org\/10.3390\/biology13040253.","journal-title":"Biology"},{"key":"4082_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117641","volume":"181","author":"L Dilworth","year":"2024","unstructured":"Dilworth L, Stennett D, Facey A, Omoruyi F, Mohansingh S, Omoruyi FO. Diabetes and the associated complications: the role of antioxidants in diabetes therapy and care. Biomed Pharmacother. 2024;181:117641. https:\/\/doi.org\/10.1016\/j.biopha.2024.117641.","journal-title":"Biomed Pharmacother"},{"key":"4082_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.769341","author":"HB Taylor","year":"2021","unstructured":"Taylor HB, Vasu C. Impact of prebiotic \u03b2-glucan treatment at juvenile age on the gut microbiota composition and the eventual type 1 diabetes onset in non-obese diabetic mice. Front Nutr. 2021. https:\/\/doi.org\/10.3389\/fnut.2021.769341.","journal-title":"Front Nutr"},{"issue":"1","key":"4082_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imm.13048","volume":"157","author":"R Gudi","year":"2019","unstructured":"Gudi R, Perez N, Johnson BM, et al. Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes. Immunology. 2019;157(1):70\u201385. https:\/\/doi.org\/10.1111\/imm.13048.","journal-title":"Immunology"},{"issue":"2","key":"4082_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1381612825666190306153838","volume":"25","author":"BL Zaric","year":"2019","unstructured":"Zaric BL, Obradovic M, Sudar-Milovanovic E, Nedeljkovic J, Lazic V, Isenovic ER. Drug delivery systems for diabetes treatment. CPD. 2019;25(2):166\u201373. https:\/\/doi.org\/10.2174\/1381612825666190306153838.","journal-title":"CPD"},{"issue":"1","key":"4082_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010125","volume":"22","author":"DA Elhag","year":"2020","unstructured":"Elhag DA, Kumar M, Al Khodor S. Exploring the triple interaction between the host genome, the epigenome, and the gut microbiome in type 1 diabetes. IJMS. 2020;22(1):125. https:\/\/doi.org\/10.3390\/ijms22010125.","journal-title":"IJMS"},{"issue":"2","key":"4082_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11020069","volume":"11","author":"C Mameli","year":"2021","unstructured":"Mameli C, Ghezzi M, Mari A, et al. The diabetic lung: insights into pulmonary changes in children and adolescents with type 1 diabetes. Metabolites. 2021;11(2):69. https:\/\/doi.org\/10.3390\/metabo11020069.","journal-title":"Metabolites"},{"issue":"2","key":"4082_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/1947-2714.177311","volume":"8","author":"V Vetvicka","year":"2016","unstructured":"Vetvicka V, Vetvickova J. Addition of selenium improves immunomodulative effects of glucan. North Am J Med Sci. 2016;8(2):88. https:\/\/doi.org\/10.4103\/1947-2714.177311.","journal-title":"North Am J Med Sci"},{"key":"4082_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201601006","author":"K Chen","year":"2017","unstructured":"Chen K, Chen H, Faas MM, et al. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis. Mol Nutr Food Res. 2017. https:\/\/doi.org\/10.1002\/mnfr.201601006.","journal-title":"Mol Nutr Food Res"},{"key":"4082_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104567","volume":"91","author":"M Lo Conte","year":"2023","unstructured":"Lo Conte M, Cosorich I, Ferrarese R, et al. Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human type 1 diabetes. EBioMedicine. 2023;91:104567. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104567.","journal-title":"EBioMedicine"},{"issue":"9","key":"4082_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092520","volume":"11","author":"T Ramachandran","year":"2023","unstructured":"Ramachandran T, Manoharan D, Natesan S, et al. Synthesis and structural characterization of selenium nanoparticles\u2013Bacillus sp. MKUST-01 exopolysaccharide (SeNPs\u2013EPS) conjugate for biomedical applications. Biomedicines. 2023;11(9):2520. https:\/\/doi.org\/10.3390\/biomedicines11092520.","journal-title":"Biomedicines"},{"key":"4082_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84099-8","author":"GB Alvi","year":"2021","unstructured":"Alvi GB, Iqbal MS, Ghaith MMS, Haseeb A, Ahmed B, Qadir MI. Biogenic selenium nanoparticles (SeNPs) from citrus fruit have anti-bacterial activities. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-84099-8.","journal-title":"Sci Rep"},{"issue":"1","key":"4082_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jobcr.2024.12.011","volume":"15","author":"R Vijayalakshmi","year":"2025","unstructured":"Vijayalakshmi R, Ambalavanan N, Rajeshkumar S, Mahendra J, Sudhakar U, Parameswari D. Comparative drug release kinetics of terminalia arjuna mediated senps nanogel and ZnONPs nanogel \u2013 an in-vitro study. J Oral Biol Craniofac Res. 2025;15(1):199\u2013204. https:\/\/doi.org\/10.1016\/j.jobcr.2024.12.011.","journal-title":"J Oral Biol Craniofac Res"},{"issue":"1","key":"4082_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/01480545.2018.1491589","volume":"42","author":"N Hadrup","year":"2018","unstructured":"Hadrup N, Loeschner K, Mandrup K, et al. Subacute oral toxicity investigation of selenium nanoparticles and selenite in rats. Drug Chem Toxicol. 2018;42(1):76\u201383. https:\/\/doi.org\/10.1080\/01480545.2018.1491589.","journal-title":"Drug Chem Toxicol"},{"issue":"9","key":"4082_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/nu9091016","volume":"9","author":"V De O. Silva","year":"2017","unstructured":"De O. Silva V, Lobato R, Andrade E, et al. Effects of \u03b2-glucans ingestion on alveolar bone loss, intestinal morphology, systemic inflammatory profile, and pancreatic \u03b2-cell function in rats with periodontitis and diabetes. Nutrients. 2017;9(9):1016. https:\/\/doi.org\/10.3390\/nu9091016.","journal-title":"Nutrients"},{"key":"4082_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70130","author":"C Li","year":"2024","unstructured":"Li C, Qiao L, Ge J, et al. PLAGL1 overexpression induces cytoplasmic DNA accumulation that triggers cGAS\/STING activation. J Cell Mol Med. 2024. https:\/\/doi.org\/10.1111\/jcmm.70130.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4082_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1006\/phrs.2000.0700","volume":"42","author":"HJ Chae","year":"2000","unstructured":"Chae HJ, Kang JS, Byun JO, et al. Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. Pharmacol Res. 2000;42(4):373\u201381. https:\/\/doi.org\/10.1006\/phrs.2000.0700.","journal-title":"Pharmacol Res"},{"issue":"2","key":"4082_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","volume":"28","author":"Y Du","year":"2022","unstructured":"Du Y, Liang Z, Wang S, et al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28(2):272\u201382. https:\/\/doi.org\/10.1038\/s41591-021-01645-7.","journal-title":"Nat Med"},{"key":"4082_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113642","volume":"382","author":"G Sun","year":"2025","unstructured":"Sun G, Wu Y, Li J, et al. Quercetin liposomes conjugated with hyaluronidase: an efficient drug delivery system to block pancreatic cancer. J Control Release. 2025;382:113642. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113642.","journal-title":"J Control Release"},{"issue":"4","key":"4082_CR52","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s12013-024-01356-z","volume":"82","author":"AA Sendani","year":"2024","unstructured":"Sendani AA, Farmani M, Jahankhani K, et al. Exploring the anti-inflammatory and antioxidative potential of selenium nanoparticles biosynthesized by Lactobacillus casei 393 on an inflamed Caco-2 cell line. Cell Biochem Biophys. 2024;82(4):3265\u201376. https:\/\/doi.org\/10.1007\/s12013-024-01356-z.","journal-title":"Cell Biochem Biophys"},{"key":"4082_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106670","volume":"192","author":"S Bi Bi","year":"2024","unstructured":"Bi Bi S, Elahi I, Sardar N, et al. Exploring non-cytotoxic, antioxidant, and anti-inflammatory properties of selenium nanoparticles synthesized from Gymnema sylvestre and Cinnamon cassia extracts for herbal nanomedicine. Microb Pathog. 2024;192:106670. https:\/\/doi.org\/10.1016\/j.micpath.2024.106670.","journal-title":"Microb Pathog"},{"issue":"27","key":"4082_CR54","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.1080\/10408398.2023.2217727","volume":"64","author":"L Yu","year":"2023","unstructured":"Yu L, Gao Y, Ye Z, et al. Interaction of beta-glucans with gut microbiota: dietary origins, structures, degradation, metabolism, and beneficial function. Crit Rev Food Sci Nutr. 2023;64(27):9884\u2013909. https:\/\/doi.org\/10.1080\/10408398.2023.2217727.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"4082_CR55","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s12011-020-02283-9","volume":"199","author":"J Xi","year":"2020","unstructured":"Xi J, Zhang Q, Wang J, Guo R, Wang L. Factors influencing selenium concentration in community-dwelling patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2020;199(5):1657\u201363. https:\/\/doi.org\/10.1007\/s12011-020-02283-9.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"4082_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15020138","volume":"15","author":"L Blok","year":"2025","unstructured":"Blok L, Hanssen N, Nieuwdorp M, Rampanelli E. From microbes to metabolites: advances in gut microbiome research in type 1 diabetes. Metabolites. 2025;15(2):138. https:\/\/doi.org\/10.3390\/metabo15020138.","journal-title":"Metabolites"},{"issue":"2","key":"4082_CR57","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/gutjnl-2020-323664","volume":"71","author":"M Rouland","year":"2021","unstructured":"Rouland M, Beaudoin L, Rouxel O, et al. Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia. Gut. 2021;71(2):296\u2013308. https:\/\/doi.org\/10.1136\/gutjnl-2020-323664.","journal-title":"Gut"},{"issue":"5","key":"4082_CR58","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1210\/jc.2016-3222","volume":"102","author":"S Pellegrini","year":"2017","unstructured":"Pellegrini S, Sordi V, Bolla AM, et al. Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota. J Clin Endocrinol Metab. 2017;102(5):1468\u201377. https:\/\/doi.org\/10.1210\/jc.2016-3222.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4082_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cyto.2011.03.023","volume":"55","author":"S Devaraj","year":"2011","unstructured":"Devaraj S, Tobias P, Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine. 2011;55(3):441\u20135. https:\/\/doi.org\/10.1016\/j.cyto.2011.03.023.","journal-title":"Cytokine"},{"issue":"4","key":"4082_CR60","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jdiacomp.2016.01.014","volume":"30","author":"R Pahwa","year":"2016","unstructured":"Pahwa R, Nallasamy P, Jialal I. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J Diabetes Complications. 2016;30(4):563\u201372. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.01.014.","journal-title":"J Diabetes Complications"},{"issue":"8","key":"4082_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.01.014","volume":"14","author":"J Wu","year":"2024","unstructured":"Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W. Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. J Pharm Anal. 2024;14(8):100946. https:\/\/doi.org\/10.1016\/j.jpha.2024.01.014.","journal-title":"J Pharm Anal"},{"key":"4082_CR62","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2147\/dddt.s407122","volume":"17","author":"Y Li","year":"2023","unstructured":"Li Y, Zhu S, Luo J, et al. The protective effect of selenium nanoparticles in osteoarthritis: in vitro and in vivo studies. Drug Des Devel Ther. 2023;17:1515\u201329. https:\/\/doi.org\/10.2147\/dddt.s407122.","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"4082_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/nano11082005","volume":"11","author":"A Rehman","year":"2021","unstructured":"Rehman A, John P, Bhatti A. Biogenic selenium nanoparticles: potential solution to oxidative stress mediated inflammation in rheumatoid arthritis and associated complications. Nanomaterials. 2021;11(8):2005. https:\/\/doi.org\/10.3390\/nano11082005.","journal-title":"Nanomaterials"},{"key":"4082_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11156-x","author":"AY Soliman","year":"2025","unstructured":"Soliman AY, Elguindy NM, Saleh AM, Balbaa M. Biochemical and molecular evaluation of resveratrol and selenium nanoparticles in managing type 2 diabetes and its complications. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-11156-x.","journal-title":"Sci Rep"},{"issue":"3","key":"4082_CR65","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12026-022-09355-z","volume":"71","author":"BA Ozgur","year":"2023","unstructured":"Ozgur BA, Cinar SA, Coskunpinar E, et al. The role of cytokines and T-bet, GATA3, ROR-\u03b3t, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of type 1 diabetes. Immunol Res. 2023;71(3):451\u201362. https:\/\/doi.org\/10.1007\/s12026-022-09355-z.","journal-title":"Immunol Res"},{"issue":"3","key":"4082_CR66","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.imbio.2012.05.010","volume":"218","author":"JNU Yaochite","year":"2013","unstructured":"Yaochite JNU, Caliari-Oliveira C, Davanso MR, et al. Dynamic changes of the Th17\/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis. Immunobiology. 2013;218(3):338\u201352. https:\/\/doi.org\/10.1016\/j.imbio.2012.05.010.","journal-title":"Immunobiology"},{"issue":"9","key":"4082_CR67","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s00125-020-05200-w","volume":"63","author":"M Rosenzwajg","year":"2020","unstructured":"Rosenzwajg M, Salet R, Lorenzon R, et al. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a phase I\/II randomised, double-blind, placebo-controlled, dose-finding study. Diabetologia. 2020;63(9):1808\u201321. https:\/\/doi.org\/10.1007\/s00125-020-05200-w.","journal-title":"Diabetologia"},{"issue":"6","key":"4082_CR68","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10517-022-05458-7","volume":"172","author":"VV Ivanov","year":"2022","unstructured":"Ivanov VV, Buyko EE, Ufandeev AA, et al. Insulin resistance in experimental type 1 diabetes mellitus. Bull Exp Biol Med. 2022;172(6):691\u20134. https:\/\/doi.org\/10.1007\/s10517-022-05458-7.","journal-title":"Bull Exp Biol Med"},{"issue":"5","key":"4082_CR69","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1159\/000539120","volume":"98","author":"J Weiskorn","year":"2024","unstructured":"Weiskorn J, Danne T. Moving from insulin substitution to the treatment of the underlying autoimmune disease in type 1 diabetes. Horm Res Paediatr. 2024;98(5):558\u201365. https:\/\/doi.org\/10.1159\/000539120.","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"4082_CR70","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/13543784.2024.2439501","volume":"33","author":"X Ning","year":"2024","unstructured":"Ning X, Munir KM, Davis SN. Drugs stimulating insulin secretion in early clinical development for the treatment of type 1 diabetes: what\u2019s new? Expert Opin Investig Drugs. 2024;33(12):1199\u2013208. https:\/\/doi.org\/10.1080\/13543784.2024.2439501.","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"4082_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041599","volume":"15","author":"YD Muller","year":"2024","unstructured":"Muller YD, Ho P, Bluestone JA, Tang Q. Rebalancing the immune system to treat type 1 diabetes. Cold Spring Harb Perspect Med. 2024;15(8):a041599. https:\/\/doi.org\/10.1101\/cshperspect.a041599.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"4082_CR72","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13340-024-00748-z","volume":"15","author":"EM Ling","year":"2024","unstructured":"Ling EM, Lemos JRN, Hirani K, von Herrath M. Type 1 diabetes: immune pathology and novel therapeutic approaches. Diabetol Int. 2024;15(4):761\u201376. https:\/\/doi.org\/10.1007\/s13340-024-00748-z.","journal-title":"Diabetol Int"},{"key":"4082_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01086","author":"CEB Couri","year":"2018","unstructured":"Couri CEB, Malmegrim KCR, Oliveira MC. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01086.","journal-title":"Front Immunol"},{"issue":"3","key":"4082_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12015-023-10668-1","volume":"20","author":"V Mohammadi","year":"2023","unstructured":"Mohammadi V, Maleki AJ, Nazari M, et al. Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current progress and future approaches. Stem Cell Rev Rep. 2023;20(3):585\u2013600. https:\/\/doi.org\/10.1007\/s12015-023-10668-1.","journal-title":"Stem Cell Rev Rep"},{"key":"4082_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.754401","author":"CH Wang","year":"2022","unstructured":"Wang CH, Yen HR, Lu WL, et al. Adjuvant probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 attenuate glycemic levels and inflammatory cytokines in patients with type 1 diabetes mellitus. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.754401.","journal-title":"Front Endocrinol"},{"key":"4082_CR76","doi-asserted-by":"publisher","unstructured":"Garcia-Gutierrez E, O\u2019Mahony AK, Dos Santos RS, Marroqu\u00ed L, Cotter PD. Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications. Gut Microbes. 2024;16(1). https:\/\/doi.org\/10.1080\/19490976.2024.2401654.","DOI":"10.1080\/19490976.2024.2401654"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04082-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:47:08Z","timestamp":1776826028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4082"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04082-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Ethics Committee of The Second Affiliated Hospital of Nanchang University.\u00a0Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}